MD2722B2 - Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis - Google Patents

Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis

Info

Publication number
MD2722B2
MD2722B2 MDA20020265A MD20020265A MD2722B2 MD 2722 B2 MD2722 B2 MD 2722B2 MD A20020265 A MDA20020265 A MD A20020265A MD 20020265 A MD20020265 A MD 20020265A MD 2722 B2 MD2722 B2 MD 2722B2
Authority
MD
Moldova
Prior art keywords
vitamin
pharmaceutical composition
magnesium
osteoporosis
prophylaxis
Prior art date
Application number
MDA20020265A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD20020265A (en
Inventor
Любослав Разус
Юрай ВЕНДЛ
Иван Варга
Пётр ШИМЕК
Original Assignee
Словакофарма А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Словакофарма А.С. filed Critical Словакофарма А.С.
Publication of MD20020265A publication Critical patent/MD20020265A/en
Publication of MD2722B2 publication Critical patent/MD2722B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, namely to a pharmaceutical composition that may be used for prophylaxis and treatment of osteoporosis.Summary of the invention consists in that the pharmaceutical composition contains calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, where to a dose of calcium of 150…1500 mg, preferably of 200…600 mg, may be taken 100…1000 IU, preferably 400…900 IU of vitamin D, or 20…500 mg, preferably 150…300 mg of magnesium, wherein the active substances containing calcium and magnesium are finely grounded so that at least 80% of particles have dimensions under 75 µm and, moreover, contain conventional adjuvants and pharmaceutically acceptable derivatives of starch, preferably diphosphate starch in a quantity of 5…40 wt%, preferably of 15…25 wt%; substances of vegetal origin able to form xerogels with the water, preferably carragheenan, in a quantity of 0,1…1,0 wt%, preferably of 0,2…0,6 wt%.The aforesaid composition represents a quick-soluble powder, which at the addition of liquids, after a short mixing, form a pudding resembling gellylike suspension, well-tolerated by patients.
MDA20020265A 2000-04-06 2001-03-15 Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis MD2722B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK498-2000A SK284948B6 (en) 2000-04-06 2000-04-06 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin D or mixture of calcium and magnesium in a new formulation
PCT/SK2001/000004 WO2001076610A1 (en) 2000-04-06 2001-03-15 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation

Publications (2)

Publication Number Publication Date
MD20020265A MD20020265A (en) 2003-05-31
MD2722B2 true MD2722B2 (en) 2005-03-31

Family

ID=20435843

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20020265A MD2722B2 (en) 2000-04-06 2001-03-15 Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis

Country Status (10)

Country Link
EP (1) EP1274447A1 (en)
AU (1) AU2001239668A1 (en)
BG (1) BG107227A (en)
CZ (1) CZ303069B6 (en)
EE (1) EE200200584A (en)
MD (1) MD2722B2 (en)
PL (1) PL357777A1 (en)
RU (1) RU2002130196A (en)
SK (1) SK284948B6 (en)
WO (1) WO2001076610A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
ATE516019T1 (en) 2004-05-11 2011-07-15 Egalet Ltd SWELLABLE DOSAGE FORM WITH GELLAN GUMMIT
UA95093C2 (en) 2005-12-07 2011-07-11 Нікомед Фарма Ас Method for the preparation of calcium-containing compound
RS52239B (en) * 2009-03-26 2012-10-31 Pulmatrix, Inc. Pharmaceutical formaulations and methods for treating respiratory tract infections
ES2625260T5 (en) 2009-03-26 2020-07-29 Pulmatrix Operating Co Inc Dry powder formulations and methods for the treatment of lung diseases
EP2448571B1 (en) 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
CA2812414C (en) 2010-09-29 2020-09-22 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
JP2015509788A (en) 2012-02-29 2015-04-02 パルマトリックス，インコーポレイテッド Dry powder suitable for inhalation
JP6473738B2 (en) 2013-04-01 2019-02-20 パルマトリックス，インコーポレイテッド Tiotropium dry powder
JO3456B1 (en) 2015-05-13 2020-07-05 H Lundbeck As Vortioxetine pyroglutamate
RU2726438C2 (en) * 2018-11-14 2020-07-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Method for production of a dry high protein milk mixture for prevention of osteopenia in children and adolescents with gee's disease
CN109453126A (en) * 2018-12-07 2019-03-12 浙江核力欣健药业有限公司 A kind of calcium carbonate D3Composition of chewable tablets and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587399A (en) * 1992-12-23 1996-12-24 Abbott Laboratories Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
WO1999047122A1 (en) * 1998-03-16 1999-09-23 Smtm Group, Llc Chewable calcium supplement and method for making it

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
CA1297035C (en) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Chewable, non-gritty calcium citrate tablet
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587399A (en) * 1992-12-23 1996-12-24 Abbott Laboratories Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
WO1999047122A1 (en) * 1998-03-16 1999-09-23 Smtm Group, Llc Chewable calcium supplement and method for making it

Also Published As

Publication number Publication date
EP1274447A1 (en) 2003-01-15
MD20020265A (en) 2003-05-31
EE200200584A (en) 2004-04-15
PL357777A1 (en) 2004-07-26
AU2001239668A1 (en) 2001-10-23
CZ303069B6 (en) 2012-03-21
RU2002130196A (en) 2004-03-27
BG107227A (en) 2003-05-30
SK284948B6 (en) 2006-03-02
WO2001076610A1 (en) 2001-10-18
SK4982000A3 (en) 2001-10-08

Similar Documents

Publication Publication Date Title
MD2722B2 (en) Pharmaceutical composition containing calcium carbonate or mixture thereof with magnesium hydroxycarbonate or with vitamin D, used for prophylaxis or treatment of osteoporosis
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
WO1999059544A3 (en) Orally disintegrable tablets
US3590117A (en) Long-lasting troche containing guar gum
JP2010215611A (en) Medicinal preparation containing loxoprofen
IE48879B1 (en) An analgesic effervescent powder and process for its preparation
US3632778A (en) Tablets containing l-dopa
ZA200301007B (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations.
US5922351A (en) Lubricants for use in tabletting
HUP0004363A2 (en) Solid pharmaceutical compositions containing miltefosine for use in the treatment of leishmaniasis
JP6580414B2 (en) Herbal powder-containing tablets
WO2008079343A3 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
JP2001097856A (en) Antitussive
KR20010052819A (en) Cyclophosphamide coated tablets
US2967131A (en) Therapeutic composition
EP0305968A3 (en) Compositions against protozoal diseases
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
CA1119517A (en) Oral formulations for human use
JP4899304B2 (en) Solid preparation for internal use containing ambroxol hydrochloride
EP0272393A3 (en) Pharmaceutical combination
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
UA79567C2 (en) Orodispersible pharmaceutical composition of antithrombolic compound
GB2336999A (en) High-dosage triclosan compositions
KR900701284A (en) Finely divided cholestipol hydrochloride